Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs Charles Schwab Corporation Common Stock (SCHW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs Charles Schwab Corporation Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Charles Schwab Corporation Common Stock trades at $96.87 (market cap $165.29B). The key difference: Charles Schwab Corporation Common Stock is far larger — about 96.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Charles Schwab Corporation Common Stock pays a 1.34% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Charles Schwab Corporation Common Stock for 85 Days on average.
| NUVB | SCHW | |
|---|---|---|
Market Cap | $1.71B | $165.29B |
Volume | 5,448,712 | 7,114,246 |
Sector | Health | Financials |
52-Week High | $9.54 | $113.65 |
52-Week Low | $3.41 | $85.35 |
Typical Hold Time | 0 Days | 85 Days |
Enterprise Value | $1.30B | $151.73B |
Dividend Yield | — | 1.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Charles Schwab (SCHW) trades at $96.87, up 0.07% with bearish technical signals but strong fundamentals. The stock shows consistent earnings beats with Q2 2026 EPS of $1.62 exceeding expectations of $1.56. Revenue grew to $23.92B in 2025 with 37% profit margin, while analyst consensus remains bullish with a $119.92 price target. Recent developments include dual listing on the Texas Stock Exchange and AI integration partnerships.
SCHW presents a compelling value opportunity with attractive valuation metrics (P/E 17.41) and strong profitability (ROE 22.45%). Near-term risks include technical bearish momentum and market volatility, but long-term growth prospects in the expanding e-brokerage market and operational efficiency gains support upside potential to analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About Charles Schwab Corporation Common Stock
Charles Schwab operates in brokerage, banking, and asset-management businesses. The company runs a large network of brick-and-mortar brokerage branch offices, a well-established online investing website, and has mobile trading capabilities. It also operates a bank and a proprietary asset management business and offers services to independent investment advisors. The company is among the largest firms in the investment business, with over $8 trillion of client assets at the end of 2021. Nearly all of its revenue is from the United States.
Read more on SCHW →
